Macario Alberto J L, Conway de Macario Everly
Center of Marine Biotechnology, University of Maryland Biotechnology Institute, Baltimore, MD 21202, USA.
Front Biosci. 2007 Jan 1;12:2588-600. doi: 10.2741/2257.
Cell stressors are ubiquitous and frequent, challenging cells often, which leads to the stress response with activation of anti-stress mechanisms. These mechanisms involve a variety of molecules, including molecular chaperones also known as heat-shock proteins (Hsp). The chaperones treated in this article are proteins that assist other proteins to fold, refold, travel to their place of residence (cytosol, organelle, membrane, extracellular space), and translocate across membranes. Molecular chaperones participate in a variety of physiological processes and are widespread in organisms, tissues, and cells. It follows that chaperone failure will have an impact, possibly serious, on one or more cellular function, which may lead to disease. Chaperones must recognize and interact with proteins in need of assistance or client polypeptides (e.g., nascent at the ribosome, or partially denatured by stressors), and have to interact with other chaperones because the chaperoning mechanism involves teams of chaperone molecules, i.e., multimolecular assemblies or chaperone machines. Consequently, chaperone molecules have structural domains with distinctive functions: bind the client polypeptide, interact with other chaperone molecules to build a machine, and interact with other complexes that integrate the chaperoning network. Also, various chaperones have ATP-binding and ATPase sites because the chaperoning process requires as, a rule, energy from ATP hydrolysis. Alterations in any one of these domains due to a mutation or an aberrant post-translational modification can disrupt the chaperoning process and cause diseases termed chaperonopathies. This article presents the pathologic concept of chaperonopathy with examples, and discusses the potential of using chaperones (genes or proteins) in treatment (chaperonotherapy). In addition, emerging topics within the field of study of chaperones (chaperonology) are highlighted, e.g., genomics (chaperonomics), systems biology, extracellular chaperones, and anti-chaperone antibodies.
细胞应激源普遍且频繁,经常对细胞造成挑战,从而引发应激反应并激活抗应激机制。这些机制涉及多种分子,包括也被称为热休克蛋白(Hsp)的分子伴侣。本文所讨论的分子伴侣是协助其他蛋白质折叠、重新折叠、转运至其驻留位置(细胞质、细胞器、膜、细胞外空间)以及跨膜转运的蛋白质。分子伴侣参与多种生理过程,广泛存在于生物体、组织和细胞中。由此可见,分子伴侣功能异常将对一种或多种细胞功能产生影响,甚至可能是严重影响,进而可能导致疾病。分子伴侣必须识别并与需要协助的蛋白质或客户多肽相互作用(例如,核糖体上新合成的多肽,或因应激源而部分变性的多肽),并且必须与其他分子伴侣相互作用,因为伴侣机制涉及分子伴侣分子团队,即多分子组装体或分子伴侣机器。因此,分子伴侣分子具有具有独特功能的结构域:结合客户多肽、与其他分子伴侣分子相互作用以构建机器,以及与整合伴侣网络的其他复合物相互作用。此外,各种分子伴侣具有ATP结合和ATP酶位点,因为通常情况下,伴侣过程需要ATP水解提供能量。由于突变或异常的翻译后修饰导致这些结构域中的任何一个发生改变,都可能破坏伴侣过程并引发称为伴侣病的疾病。本文通过实例介绍了伴侣病的病理概念,并讨论了使用分子伴侣(基因或蛋白质)进行治疗(伴侣疗法)的潜力。此外,还强调了分子伴侣研究领域(伴侣学)中的新兴主题,例如基因组学(伴侣组学)、系统生物学、细胞外分子伴侣和抗分子伴侣抗体。